Prevention of gestational diabetes mellitus: Where are we now?

被引:37
|
作者
Simmons, D. [1 ]
机构
[1] Univ Western Sydney, Macarthur Clin Sch, Campbelltown, NSW 2560, Australia
来源
DIABETES OBESITY & METABOLISM | 2015年 / 17卷 / 09期
关键词
gestational diabetes; glucose tolerance test; lifestyle; metformin; myoinositol; nutrition; physical activity; prevention; probiotic; vitamin D; LIFE-STYLE INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; POLYCYSTIC-OVARY-SYNDROME; EXCESSIVE WEIGHT-GAIN; OBESE PREGNANT-WOMEN; HIGH-RISK; MYOINOSITOL SUPPLEMENTATION; PHYSICAL-ACTIVITY; VITAMIN-D; GLUCOSE-METABOLISM;
D O I
10.1111/dom.12495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gestational diabetes mellitus (GDM) is increasing at a rapid rate, driven by the increasing proportion of the population that is overweight/obese from a young age. More than 25 randomized controlled trials testing whether GDM can be prevented have now reported their findings, but only four different interventions have shown a reduction in the proportion of women with GDM (healthy eating alone, healthy eating with physical activity, myoinositol supplementation and probiotic treatment), and these results have not been replicated. The interventions tested to date include different diets and different forms of physical activity, in combination or alone, vitamin D, myoinositol, probiotics and metformin. Studies could be improved by using the International Association of Diabetes and Pregnancy Study Group criteria for GDM (which are probably more sensitive to change because of their multiple time points), targeting and tailoring interventions to subgroups most likely to benefit, and separating those with GDM early in pregnancy from those developing GDMde novo. The greatest societal benefit is likely to arise from population-based lifestyle approaches which include those women yet to become pregnant and those who are already pregnant and their families; an approach that is yet to be fully tested.
引用
收藏
页码:824 / 834
页数:11
相关论文
共 50 条
  • [21] Gestational Diabetes Mellitus Pharmacological Prevention and Treatment
    Christos, Chatzakis
    Paolo, Cavoretto
    Alexandros, Sotiriadis
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (36) : 3833 - 3840
  • [22] Diagnosis, prevention and management of gestational diabetes mellitus
    Wang Chen
    Yang Hui-Xia
    慢性疾病与转化医学(英文), 2016, 2 (04)
  • [23] Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
    Sobota-Grzeszyk, Angelika
    Kuzmicki, Mariusz
    Szamatowicz, Jacek
    JOURNAL OF DIABETES RESEARCH, 2019, 2019
  • [24] Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus
    Tahir, Faryal
    Majid, Zainab
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [25] Prevention of type 1 diabetes: where we are and where we are going
    Frontino, Giulio
    Guercio, Nuzio S.
    Scaramuzza, Andrea
    D'Annunzio, Giuseppe
    Toni, Sonia
    Citriniti, Felice
    Bonfanti, Riccardo
    MINERVA PEDIATRICS, 2021, 73 (06): : 486 - 503
  • [26] Probiotics for Prevention of Necrotizing Enterocolitis Where Are We Now?
    Parker, Leslie A.
    JOURNAL OF PERINATAL & NEONATAL NURSING, 2022, 36 (03) : 231 - 232
  • [27] Stroke Prevention in Atrial Fibrillation: Where are We Now?
    Ahmad, Yousif
    Lip, Gregory Y. H.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2012, 6 : 65 - 78
  • [28] Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus
    Moon, Joon Ho
    Kwak, Soo Heon
    Jang, Hak C.
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (01): : 26 - 41
  • [29] "Vitamin D and lifestyle intervention for gestational diabetes mellitus prevention". European project for prevention of gestational diabetes
    Desoye, G.
    DIABETOLOGE, 2012, 8 (08): : 647 - 651
  • [30] COVID-19 and diabetes — where are we now?
    Rüdiger Groß
    Alexander Kleger
    Nature Metabolism, 2022, 4 : 1611 - 1613